Vandana Batra

Employment

• Children's Hospital of Philadelphia

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Cryoablation of Malignancies and Aggressive Benign Diseases in Children: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
  Journal of Vascular and Interventional Radiology 2026 DOI: 10.1016/j.jvir.2026.109000
  +Save
• A High‐Sensitivity Circulating Nucleic Acid Sequencing Assay for Assessing Treatment Response to Alectinib in a Pediatric Patient With ALK‐Rearranged Non–Small Cell Lung Cancer
  Pediatric Blood & Cancer 2026 DOI: 10.1002/1545-5017.70322
  +Save
• Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.c.6532614.v1
  +Save
• Data from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.c.6532614
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487934.v1
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487928.v1
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487922.v1
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487931.v1
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487925.v1
  +Save
• Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
  2023 DOI: 10.1158/1078-0432.22487931
  +Save